Microvascular Complications of Diabetes Mellitus: Renal Protection Accompanies Cardiovascular Protection

被引:59
|
作者
Brown, W. Virgil [1 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2008年 / 102卷 / 12A期
关键词
D O I
10.1016/j.amjcard.2008.09.068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The microvascular complications of diabetes mellitus confer substantial morbidity and impair patient quality of life. Dyslipidemia and prolonged hyperglycemia promote an increase in oxidative stress, inflammation, and vascular damage, which together promote endothelial dysfunction and are associated with macrovascular and microvascular complications. Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. Diabetic nephropathy is the most common cause of end-stage renal disease in developed countries, and its prevalence is increasing. Preventing or limiting the progression of diabetic nephropathy, as demonstrated in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial, may prevent or delay renal complications, as well as convey important cardioprotective benefits in patients with type 2 diabetes. (c) Published by Elsevier Inc. (Am J Cardiol 2008;102[suppl]:10L-13L)
引用
收藏
页码:10L / 13L
页数:4
相关论文
共 50 条
  • [21] Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus
    Freedman, Barry I.
    Bowden, Donald W.
    Sale, Michele M.
    Langefeld, Carl D.
    Rich, Stephen S.
    HYPERTENSION, 2006, 48 (01) : 8 - 13
  • [22] Effect of Dapagliflozin on renal protection in patients with uncontrolled type 2 diabetes mellitus
    张德园
    ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (01) : 21 - 22
  • [23] MICROVASCULAR COMPLICATIONS OF DIABETES-MELLITUS AND GLYCEMIC CONTROL
    SHEFFIELD, MV
    ANNALS OF INTERNAL MEDICINE, 1987, 106 (04) : 638 - 639
  • [24] Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
    Demirel, Fatma
    Tepe, Derya
    Kara, Ozlem
    Esen, Ihsan
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2013, 5 (03) : 145 - 149
  • [25] Serum biomarkers for predicting microvascular complications of diabetes mellitus
    Wang, Jiajia
    Song, Xiaoyi
    Xia, Ziqiao
    Feng, Shu
    Zhang, Hangfeng
    Xu, Chengjie
    Zhang, Hui
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (08) : 703 - 713
  • [26] Plasma thrombomodulin: A marker for microvascular complications in diabetes mellitus
    Gabat, S
    Keller, C
    Kempe, HP
    Amiral, J
    Ziegler, R
    Ritz, E
    Bergis, KH
    Wahl, P
    Nawroth, P
    VASA-JOURNAL OF VASCULAR DISEASES, 1996, 25 (03): : 233 - 241
  • [27] The changes of coagulation parameters and microvascular complications in diabetes mellitus
    Bolaman, Zahit
    Kok, Fayat
    Kadikoylu, Gurhan
    Kiylioglu, Nefati
    Guney, Engin
    Akyol, Ali
    ENDOCRINOLOGIST, 2007, 17 (04): : 196 - 199
  • [28] Clustering of microvascular complications in Type 1 diabetes mellitus
    Bjerg, Lasse
    Hulman, Adam
    Charles, Morten
    Jorgensen, Marit Eika
    Witte, Daniel Rinse
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (04) : 393 - 399
  • [29] NONENZYMATIC ACETYLATION OF PROTEINS BY ASPIRIN AS PROTECTION AGAINST THE SECONDARY COMPLICATIONS OF DIABETES-MELLITUS
    HUNOPFER, C
    MATASEGREDA, JF
    ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA, 1986, 36 (03): : 313 - 316
  • [30] Strategies for Renal Protection in Cardiovascular Interventions
    Ali, Ziad A.
    Escaned, Javier
    Dudek, Dariusz
    Radhakrishnan, Jai
    Galougahi, Keyvan Karimi
    KOREAN CIRCULATION JOURNAL, 2022, 52 (07) : 485 - 495